In idiopathic pulmonary fibrosis, higher risk of mortality and lung transplant is linked to small decreases in FVC% predicted and DLCO% predicted.

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly ...

New treatment approach shows potential in reversing lung damage caused by idiopathic pulmonary fibrosis using immune-based ...

Tulane scientists found that an FDA-approved cancer drug may help the immune system clear out damaged cells that cause lung ...

Have you ever heard of idiopathic pulmonary fibrosis (IPF)? Better yet, can you pronounce idiopathic pulmonary fibrosis?

Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

Researchers found significant sex-based differences in ILD in patients with interdisciplinary indications for complete ...

IPF is rapidly progressive and causes scarring in the lungs, making it difficult to breathe. Approximately 50% of patients die within three years of diagnosis, and current treatments can only slow ...